GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » China Nepstar Chain Drugstore Ltd (NYSE:NPD) » Definitions » Return-on-Tangible-Equity

China Nepstar Chain Drugstore (China Nepstar Chain Drugstore) Return-on-Tangible-Equity : 3.65% (As of Mar. 2016)


View and export this data going back to 2007. Start your Free Trial

What is China Nepstar Chain Drugstore Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. China Nepstar Chain Drugstore's annualized net income for the quarter that ended in Mar. 2016 was $4.6 Mil. China Nepstar Chain Drugstore's average shareholder tangible equity for the quarter that ended in Mar. 2016 was $126.3 Mil. Therefore, China Nepstar Chain Drugstore's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2016 was 3.65%.

The historical rank and industry rank for China Nepstar Chain Drugstore's Return-on-Tangible-Equity or its related term are showing as below:

NPD's Return-on-Tangible-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 9.91
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

China Nepstar Chain Drugstore Return-on-Tangible-Equity Historical Data

The historical data trend for China Nepstar Chain Drugstore's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Nepstar Chain Drugstore Return-on-Tangible-Equity Chart

China Nepstar Chain Drugstore Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
Return-on-Tangible-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.62 8.02 1.36 -1.74 4.90

China Nepstar Chain Drugstore Quarterly Data
Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16
Return-on-Tangible-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.74 4.49 -1.39 18.58 3.65

Competitive Comparison of China Nepstar Chain Drugstore's Return-on-Tangible-Equity

For the Pharmaceutical Retailers subindustry, China Nepstar Chain Drugstore's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Nepstar Chain Drugstore's Return-on-Tangible-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, China Nepstar Chain Drugstore's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where China Nepstar Chain Drugstore's Return-on-Tangible-Equity falls into.



China Nepstar Chain Drugstore Return-on-Tangible-Equity Calculation

China Nepstar Chain Drugstore's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2015 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2015 )  (A: Dec. 2014 )(A: Dec. 2015 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2015 )  (A: Dec. 2014 )(A: Dec. 2015 )
=6.175/( (125.602+126.287 )/ 2 )
=6.175/125.9445
=4.90 %

China Nepstar Chain Drugstore's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2016 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: Mar. 2016 )  (Q: Dec. 2015 )(Q: Mar. 2016 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: Mar. 2016 )  (Q: Dec. 2015 )(Q: Mar. 2016 )
=4.616/( (126.287+126.4)/ 2 )
=4.616/126.3435
=3.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Mar. 2016) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


China Nepstar Chain Drugstore  (NYSE:NPD) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


China Nepstar Chain Drugstore Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of China Nepstar Chain Drugstore's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


China Nepstar Chain Drugstore (China Nepstar Chain Drugstore) Business Description

Traded in Other Exchanges
N/A
Address
China Nepstar Chain Drugstore Ltd was incorporated in the Cayman Islands in August 2004. The Company operates retail drugstore business. The Company provides professional and convenient pharmacy services and other merchandise, including over-the-counter drugs, nutritional supplements, herbal products, personal care products, family care products, as well as convenience products including consumable, seasonal and promotional items. It also offers private label products. The Company offers 523 nutritional supplements, including a variety of healthcare supplements, vitamins, minerals and dietary products. Its other products include personal care products such as skin care, hair care and beauty products, family care products such as portable medical devices for family use, birth control and early pregnancy test products, and convenience products, including soft drinks, packaged snacks, cleaning agents and stationery. The other products also include seasonal and promotional items tailored to local consumer demand for convenience and quality. The Company also provides ancillary services such as providing free blood pressure measurements in its stores. The Company competes with other retail drugstore chains or independent drugstores. As a distributor and retailer of pharmaceutical products, the Company is subject to regulation and oversight by different levels of the food and drug administration in China, in particular, the State Food and Drug Administration, or the SFDA.

China Nepstar Chain Drugstore (China Nepstar Chain Drugstore) Headlines